a public good project by the
Synthesis
Company
of California

Christopher A Lamb | doi.page

0 works0 citations0 h-index

Christopher A Lamb

Newcastle upon Tyne Hospitals NHS Foundation Trust(GB)Newcastle University(GB)

Inflammatory Bowel Disease, Microscopic Colitis, COVID-19 Clinical Research Studies, Gut microbiota and health, Infant Nutrition and Health

→ British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults(2019)2,254 cited
→ Genome-wide association study implicates immune activation of multiple integrin genes in inflammatory bowel disease(2017)1,510 cited
→ Etrolizumab as induction therapy for ulcerative colitis: a randomised, controlled, phase 2 trial(2014)451 cited
→ Infliximab is associated with attenuated immunogenicity to BNT162b2 and ChAdOx1 nCoV-19 SARS-CoV-2 vaccines in patients with IBD(2021)276 cited
→ British Society of Gastroenterology guidance for management of inflammatory bowel disease during the COVID-19 pandemic(2020)256 cited
→ Human milk oligosaccharide DSLNT and gut microbiome in preterm infants predicts necrotising enterocolitis(2020)209 cited

→ Large-scale sequencing identifies multiple genes and rare variants associated with Crohn’s disease susceptibility(2022)

176 cited